Filing Details
- Accession Number:
- 0001415889-24-018407
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-06-28 16:06:40
- Reporting Period:
- 2024-06-26
- Accepted Time:
- 2024-06-28 16:06:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1786205 | Arcellx Inc. | ACLX | Biological Products, (No Disgnostic Substances) (2836) | 472855917 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1930862 | Michelle Gilson | C/O Arcellx, Inc. 800 Bridge Parkway Redwood City CA 94065 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-06-26 | 12,326 | $53.68 | 7,466 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-06-26 | 551 | $54.25 | 6,915 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on December 18, 2023 and subsequently modified March 27, 2024.
- Represents the weighted average share price of an aggregate total of 12,326 shares sold in the price range of $53.18 to $54.17 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average share price of an aggregate total of 551 shares sold in the price range of $54.18 to $54.44 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
